lactulose has been researched along with Primary Peritonitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chaiwarith, R; Narongchai, T; Nochaiwong, S; Noppakun, K; Ruengorn, C; Vongsanim, S; Wongsawad, U | 1 |
| Baik, SK; Chang, Y; Cho, EJ; Cho, H; Cho, YY; Kang, SH; Kim, MY; Kim, YJ; Lee, JH; Lee, YB; Nam, JY; Yoo, JJ; Yoon, JH; Yu, SJ | 1 |
| Morillas, RM; Planas, R; Sala, M | 1 |
| Khosravani, H; Perri, GA | 1 |
| Bruns, T; Reuken, PA; Stallmach, A; Stengel, S; Vogt, A | 1 |
| Sharma, BC; Sharma, P | 1 |
| Aussel, C; Bories, PN; Campillo, B; Devanlay, M; Pernet, P; Richardet, JP | 1 |
| Grünewald, T; Huchzermeyer, H; Schumann, C | 1 |
2 review(s) available for lactulose and Primary Peritonitis
| Article | Year |
|---|---|
[Prevention of hepatic encephalopathy].
Topics: Anti-Bacterial Agents; Central Nervous System Depressants; Contraindications; Diuretics; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Intestinal Absorption; Lactulose; Liver Cirrhosis; Liver Transplantation; Meta-Analysis as Topic; Peritonitis; Portasystemic Shunt, Surgical; Postoperative Complications; Recurrence; Rifamycins; Rifaximin; Risk Factors; Sugar Alcohols | 2014 |
Complications of end-stage liver disease.
Topics: Adrenergic beta-Antagonists; Anti-Bacterial Agents; Ascites; Bacterial Infections; Disease Management; End Stage Liver Disease; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Lactulose; Ligation; Middle Aged; Palliative Care; Paracentesis; Peritonitis | 2016 |
1 trial(s) available for lactulose and Primary Peritonitis
| Article | Year |
|---|---|
Comparative effectiveness of lactulose and sennosides for the prevention of peritoneal dialysis-related peritonitis: an open-label, randomized, active-controlled trial.
Topics: Adult; Aged; Comparative Effectiveness Research; Female; Gastrointestinal Agents; Humans; Lactulose; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Proportional Hazards Models; Sennosides; Thailand; Treatment Outcome | 2021 |
5 other study(ies) available for lactulose and Primary Peritonitis
| Article | Year |
|---|---|
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Peritonitis; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Secondary Prevention | 2017 |
Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bacterial Translocation; Case-Control Studies; Disease-Free Survival; Female; Gastrointestinal Microbiome; Hospitalization; Humans; Inflammation Mediators; Intestine, Small; Kaplan-Meier Estimate; Lactulose; Linear Models; Liver Cirrhosis; Male; Mannitol; Middle Aged; Peritonitis; Permeability; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors | 2016 |
Rifaximin treatment in hepatic encephalopathy.
Topics: Anti-Infective Agents; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Peritonitis; Rifamycins; Rifaximin | 2010 |
Intestinal permeability in liver cirrhosis: relationship with severe septic complications.
Topics: Bacteremia; Bacterial Translocation; Cell Membrane Permeability; Female; Humans; Intestinal Absorption; Intestines; Lactulose; Liver Cirrhosis; Male; Mannitol; Middle Aged; Peritonitis | 1999 |
[Prevention of spontaneous bacterial peritonitis by lactulose?].
Topics: Gastrointestinal Agents; Gram-Negative Bacterial Infections; Humans; Immunity, Mucosal; Lactulose; Peritonitis | 1999 |